These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Usefulness of rh-G-CSF in early-onset severe neutropenia in neonatal lupus syndrome.
    Author: Zuppa AA, De Luca D, De Turris P, Cota F, Tortorolo G.
    Journal: J Pediatr Hematol Oncol; 2004 Sep; 26(9):609-11. PubMed ID: 15342991.
    Abstract:
    Neutropenia is a mild and transient manifestation of neonatal lupus syndrome (NLS) in the second or third month of life. The authors describe a newborn with an early-onset severe neutropenia due to anti-Ro/SSA. In the second day of life, neutropenia has been treated with recombinant human granulocyte colony-stimulating factor (rh-G-CSF). This is the first case in which rh-G-CSF was used in NLS, and the authors studied the pharmacologic action of the drug in relationship to the pathophysiology of NLS.
    [Abstract] [Full Text] [Related] [New Search]